BRCA1 and breast cancer: Compared to the general population, the risk of recurrence of contralateral breast cancer in patients with BRCA1/2 mutation increases by two to sixfold, and the younger the age at onset, the greater the risk of recurrence (Domchek & Kaunitz, 2016).